Spero Therapeutics believes that collaborating with partners is essential to developing innovative therapies and serve the needs of patients. We have a strong record of collaborating with the government, academic institutions, and pharmaceutical companies from preclinical to clinical development.
Since its founding, Spero has built strategic partnerships to advance its multi-asset, clinical-stage pipeline. As a growing clinical stage biopharmaceutical company, we have alliances with or received funding support from the following:
We intend to continue collaborating with government agencies, non-profit foundations, and pharmaceutical partners to support the development of our product candidates.
Spero Therapeutics welcomes inquiries regarding potential partnering opportunities for our current pipeline candidates and/or in-licensing new candidates in therapeutic indications adjacent to our current pipeline including, but not limited to, rare and pulmonary diseases.
Fill out the form for more information about partnership opportunities.
